Zobrazeno 1 - 10
of 207
pro vyhledávání: '"Josette Brière"'
Autor:
Marc P. E. André, Patrice Carde, Simonetta Viviani, Monica Bellei, Catherine Fortpied, Martin Hutchings, Alessandro M. Gianni, Pauline Brice, Olivier Casasnovas, Paolo G. Gobbi, Pier Luigi Zinzani, Jehan Dupuis, Emilio Iannitto, Alessandro Rambaldi, Josette Brière, Laurianne Clément‐Filliatre, Marian Heczko, Pinuccia Valagussa, Jonathan Douxfils, Julien Depaus, Massimo Federico, Nicolas Mounier
Publikováno v:
Cancer Medicine, Vol 9, Iss 18, Pp 6565-6575 (2020)
Abstract Purpose We explored the potential overall survival (OS) benefit of bleomycin, etoposide, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine, and prednisone (BEACOPP) over doxorubicin (Adriamycin), bleomycin, vinb
Externí odkaz:
https://doaj.org/article/937d510df6514257a183dcff6818f98b
Autor:
Mathilde Lamarque, Céline Bossard, Adrien Contejean, Pauline Brice, Marie Parrens, Steven Le Gouill, Josette Brière, Reda Bouabdallah, Danielle Canioni, Hervé Tilly, Brigitte Bouchindhomme, Emmanuel Bachy, Richard Delarue, Corinne Haioun, Philippe Gaulard
Publikováno v:
Haematologica, Vol 101, Iss 3 (2016)
Externí odkaz:
https://doaj.org/article/d1e150e85f9b4805b045f2866561eedb
Autor:
Jehan Dupuis, Philippe Gaulard, Francois Hemery, Emmanuel Itti, Christian Gisselbrecht, Alain Rahmouni, Christiane Copie-Bergman, Josette Brière, Taoufik El Gnaoui, Isabelle Gaillard, Michel Meignan, Corinne Haioun
Publikováno v:
Haematologica, Vol 92, Iss 6 (2007)
Background and Objectives Diffuse large B-cell lymphomas (DLBCL) have a variable outcome, and powerful methods of prognostication are needed in order to choose the best treatment for each patient. Immunophenotypic classification of the tumor as germi
Externí odkaz:
https://doaj.org/article/c4a3814757164c0bb88bbd5ec65a0a4f
Autor:
Caroline Besson, Sophie Roetynck, Fionnuala Williams, Laurent Orsi, Corinne Amiel, Catherine Lependeven, Guillemette Antoni, Olivier Hermine, Pauline Brice, Christophe Ferme, Patrice Carde, Danielle Canioni, Josette Brière, Martine Raphael, Jean-Claude Nicolas, Jacqueline Clavel, Derek Middleton, Eric Vivier, Laurent Abel
Publikováno v:
PLoS ONE, Vol 2, Iss 5, p e406 (2007)
BackgroundEpstein-Barr virus (EBV) is the major environmental factor associated with Hodgkin's lymphoma (HL), a common lymphoma in young adults. Natural killer (NK) cells are key actors of the innate immune response against viruses. The regulation of
Externí odkaz:
https://doaj.org/article/24b05b19a2bc4515abd60a71cd8d7738
Autor:
Fabrice Jardin, Karen Leroy, Hervé Tilly, Gilles Salles, Nicolas Ketterer, Marc André, André Bosly, Frédéric Peyrade, Richard Delarue, Bertrand Coiffier, Bettina Fabiani, Danielle Canioni, Tony Petrella, Josette Brière, Christiane Copie-Bergman, Thierry Lamy, Corinne Haioun, Thierry Fest, Fabienne Desmots, Thierry J. Molina, Martin Figeac, Pauline Peyrouze, Jean-Philippe Jais, Catherine Maingonnat, Philippe Ruminy, Philippe Bertrand, Elodie Bohers, Sylvain Mareschal, Pierre-Julien Viailly, Sydney Dubois
Supplementary methods, figures, and tables Figure S1: Variant filters applied to Lymphopanel NGS data. Figure S2: Validation of variants according to SIFT and CADD scores. Figure S3: PMBL samples harbor more mutations than other DLBCL subtypes. Figur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ed5037d866560467aa14d54f59aaa4
https://doi.org/10.1158/1078-0432.22458527
https://doi.org/10.1158/1078-0432.22458527
Autor:
Fabrice Jardin, Karen Leroy, Hervé Tilly, Gilles Salles, Nicolas Ketterer, Marc André, André Bosly, Frédéric Peyrade, Richard Delarue, Bertrand Coiffier, Bettina Fabiani, Danielle Canioni, Tony Petrella, Josette Brière, Christiane Copie-Bergman, Thierry Lamy, Corinne Haioun, Thierry Fest, Fabienne Desmots, Thierry J. Molina, Martin Figeac, Pauline Peyrouze, Jean-Philippe Jais, Catherine Maingonnat, Philippe Ruminy, Philippe Bertrand, Elodie Bohers, Sylvain Mareschal, Pierre-Julien Viailly, Sydney Dubois
Purpose: Next-generation sequencing (NGS) has detailed the genomic characterization of diffuse large B-cell lymphoma (DLBCL) by identifying recurrent somatic mutations. We set out to design a clinically feasible NGS panel focusing on genes whose muta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1892cd8fb1dd9d95dbbcc3540a90e602
https://doi.org/10.1158/1078-0432.c.6523979.v1
https://doi.org/10.1158/1078-0432.c.6523979.v1
Autor:
Gandhi Damaj, Steven Le Gouill, Christophe Bonnet, Hervé Ghesquières, David Sibon, Marc André, Emmanuel Itti, Loïc Chartier, Françoise Kraeber-Bodéré, Luc Fornecker, Hervé Tilly, Vincent Ribrag, Franck Morschhauser, Jean-Philippe Jais, Caroline Bodet-Milin, Alina Berriolo-Riedinger, Krimo Bouhabdallah, Philippe Ruminy, Guillaume Cartron, Catherine Thieblemont, Remy Gressin, Reda Bouhabdallah, Corinne Haioun, Lucie Oberic, Thierry Jo Molina, René-Olivier Casasnovas, Pierre Feugier, Josette Brière, Thierry Lamy, Hervé Maisonneuve
Publikováno v:
Blood. 137:2307-2320
Rituximab plus polychemotherapy is the standard of care in diffuse large B-cell lymphoma (DLBCL). GAINED, a randomized phase 3 trial, compared obinutuzumab to rituximab. Transplant-eligible patients (18-60 years) with an untreated age-adjusted Intern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::794ce436ed3689ac359d0ad2b28dd4e0
https://doi.org/10.1182/blood.2020008750
https://doi.org/10.1182/blood.2020008750
Autor:
Pier Luigi Zinzani, Julien Depaus, P. Valagussa, Simonetta Viviani, Patrice Carde, Laurianne Clément-Filliatre, Jonathan Douxfils, Marc André, Olivier Casasnovas, Massimo Federico, Pauline Brice, Nicolas Mounier, Alessandro M. Gianni, Paolo G. Gobbi, Jehan Dupuis, Catherine Fortpied, Martin Hutchings, Emilio Iannitto, Monica Bellei, Marian Heczko, Alessandro Rambaldi, Josette Brière
Publikováno v:
Cancer Medicine, Vol 9, Iss 18, Pp 6565-6575 (2020)
Cancer Medicine
André, M P E, Carde, P, Viviani, S, Bellei, M, Fortpied, C, Hutchings, M, Gianni, A M, Brice, P, Casasnovas, O, Gobbi, P G, Zinzani, P L, Dupuis, J, Iannitto, E, Rambaldi, A, Brière, J, Clément-Filliatre, L, Heczko, M, Valagussa, P, Douxfils, J, Depaus, J, Federico, M & Mounier, N 2020, ' Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma : A pooled analysis of four randomized trials ', Cancer medicine, vol. 9, no. 18, pp. 6565-6575 . https://doi.org/10.1002/cam4.3298
Cancer medicine, Vol. 9, no. 18, p. 6565-6575 (2020)
Cancer Medicine
André, M P E, Carde, P, Viviani, S, Bellei, M, Fortpied, C, Hutchings, M, Gianni, A M, Brice, P, Casasnovas, O, Gobbi, P G, Zinzani, P L, Dupuis, J, Iannitto, E, Rambaldi, A, Brière, J, Clément-Filliatre, L, Heczko, M, Valagussa, P, Douxfils, J, Depaus, J, Federico, M & Mounier, N 2020, ' Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma : A pooled analysis of four randomized trials ', Cancer medicine, vol. 9, no. 18, pp. 6565-6575 . https://doi.org/10.1002/cam4.3298
Cancer medicine, Vol. 9, no. 18, p. 6565-6575 (2020)
Purpose We explored the potential overall survival (OS) benefit of bleomycin, etoposide, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), procarbazine, and prednisone (BEACOPP) over doxorubicin (Adriamycin), bleomycin, vinblastine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c99be92d20b893ec3b515374f66c11fc
https://researchportal.unamur.be/en/publications/2fc7e926-4cf9-4b61-870c-82a9e47fd29a
https://researchportal.unamur.be/en/publications/2fc7e926-4cf9-4b61-870c-82a9e47fd29a
Autor:
Julie Abraham, Marc Simon, Hervé Tilly, Josette Brière, Anne-Ségolène Cottereau, Lucie Oberic, Michel Meignan, Olivier Casasnovas, Olivier Fitoussi, Pascal Godmer, Christophe Fruchart, Laurence Sanhes, Laetitia Vercellino, Gian Matteo Pica, Pierre Feugier, Gilles Salles, Vincent Ribrag, Catherine Thieblemont, Armando López-Guillermo, Judith Trotman, Bernadette Corront, Loïc Chartier, Hugo Gonzalez, Franck Morschhauser, Philippe Gaulard, Bachra Choufi, Catherine Sebban, L. Roulin, Reda Bouabdallah, Sylvia Snauwaert
Publikováno v:
Blood. 135:1396-1405
Early identification of ultra-risk diffuse large B-cell lymphoma (DLBCL) patients is needed to aid stratification to innovative treatment. Previous studies suggested high baseline total metabolic tumor volume (TMTV) negatively impacts survival of DLB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc6d4f96d5c27c5db051f0bb87a9253
https://doi.org/10.1182/blood.2019003526
https://doi.org/10.1182/blood.2019003526
Autor:
Ghandi Damaj, Christophe Bonnet, T. Vander Borght, Diane Coso, Serge Bologna, Laure Lebras, Frederic Peyrade, J. N Bastie, Pierre Olivier, David Sibon, B. Fabiani, Herve Ghesquieres, Catherine Thieblemont, F. Morschhauser, Stéphanie Becker, Vincent Ribrag, H. Tilly, Josette Brière, P. Feugier, Corinne Haioun
Publikováno v:
Hematological Oncology. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8289629464d2430d038cfe0eb521fcd0
https://doi.org/10.1002/hon.5_2879
https://doi.org/10.1002/hon.5_2879